eFFECTOR Therapeutics Inc
EFTR
Get informed when a big investor buys or sells
+ FollowMarket Cap$305.79M
Close$
$-2.09
348383.3% downside
Current Fair Value
348383.3% downsideOvervalued by 348383.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $305.79 Million |
|---|---|
| Enterprise Value | $305.17 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-16.37 |
| Beta | 2.42 |
| Outstanding Shares | 2,669,960 |
Return
| Return on Equity | 1.61% |
|---|---|
| Return on Assets | 1.55% |
| Return on Invested Capital | -0.14% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -953.09 |
| Enterprise Value to Net Income | 88 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
$-6.40
Average shareholder expectationRevenue Estimate
$100,000
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-6.40
Average shareholder expectationRevenue Estimate
$100,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▲ 0.00% |
|---|---|
| Total Invested | - |
| Investors Holding | 1▲ 1.00% |
ESG Score
No data
About eFFECTOR Therapeutics Inc
CEO: Steve Worland Locust Walk Acquisition Corp. is a blank-check company formed for the purpose of acquiring or merging with one or more businesses,